Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer.
PubMed
Paper Journal Title
Cancer Cell
Paper Citation Count
50
Paper Publication Year
2018
Bio Mention
ANG, Angiogenin, EGFR, Erlotinib, PDAC, Pancreatic Cancer, Pancreatic ribonuclease, RNase, RTK, RTK families, Ribonuclease 5, angiogenin, bovine, bovine RNase A, epidermal growth factor receptor, erlotinib, human, human RNase 5, pancreatic ductal adenocarcinoma, patients, receptor tyrosine kinase, tyrosine
Mesh Descriptor
Go
Actions
Author Name
Affiliation
Jun Yao
The University of Texas MD Anderson Cancer Center
Anirban Maitra
The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center
Mien-Chie Hung
The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center, USA Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical University, Asia University
1 - 3
Column Actions
Search
Datasets